• Patented & Clinically Proven ZEMBRIN®

• Increases Mental Energy & Focus

• Elevates Mood & Cognitive Function

Key Benefits

IMPROVED FOCUS
FOCUS FREAK™ inhibits phosphodiesterase-4 (PDE), the enzyme that breaks down the secondary messenger, cyclic adenosine monophosphate (cAMP), in the brain. Higher levels of cAMP in the brain result in improved cognitive function and focus.

GREATER COGNITIVE FUNCTION
FOCUS FREAK™ contains Bacopa and Ginkgo which have a neuroprotective effect on the brain. It also supplies other key ingredients like Phosphatidylserine, Asian & American Ginseng and Acetyl-L-Carnitine that support improvements in cognitive focus and performance.

IMPROVES ABILITY TO TOLERATE STRESS
FOCUS FREAK™ contains Astragalus and Siberian Ginseng to help improve the mind and body’s ability to tolerate stress, which results in improved mental focus and function.

Key Ingredients

ZEMBRIN

Developed by a team of physicians and neuroscientists, ZEMBRIN is an exclusive and proprietary selection of Sceletium tortuosum from South Africa. The unique selection of the South African plant is rich in mesembrenone and low in mesembrine and has been developed into a clinically proven and proprietary extract that improvescognitive function and mood enhancement.

BACOPA (BACOPA MONNIERI)
Studies show that bacopa is a potent antioxidant in the brain and promotes free radical scavenger mechanisms and protects cells in the brain from damage. Bacopa is also known to modulate brain levels of the neurotransmitter serotonin and acetylcholine, which are important neurotransmitters involved in memory and other cognitive functions. Finally, bacopa’s neuroprotective effects are supported by nitric oxide-mediated cerebral vasodilation.

ASTRAGALUS (ASTRAGALUS MEMBRANACEUS)
Astragalus is an adaptogen and helps the body tolerate stress. Astragalus can help provide recovery from the neurochemical impairments in the brain that can be caused by stress.

Clinical Backup

WHY ZEMBRIN?
ZEMBRIN has been demonstrated to improve cognitive function in clinical studies. One study demonstrated for the first time in healthy subjects that ZEMBRIN selectively inhibits phosphodiesterase-4 (PDE), the enzyme that breaks down the secondary messenger, cyclic adenosine monophosphate (cAMP), in the brain.

Fact Sheet